Skip to main content
Clinical Trials/NCT02261194
NCT02261194
Completed
Not Applicable

Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration or Diabetic Retinopathy

Maisonneuve-Rosemont Hospital1 site in 1 country80 target enrollmentOctober 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
Maisonneuve-Rosemont Hospital
Enrollment
80
Locations
1
Primary Endpoint
Change in depressive symptoms
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this trial is to determine the short-term effect of a self-care intervention on depression in patients with age-related macular degeneration or diabetic retinopathy.

Registry
clinicaltrials.gov
Start Date
October 2014
End Date
February 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ellen Freeman

Associate Professor

Maisonneuve-Rosemont Hospital

Eligibility Criteria

Inclusion Criteria

  • clinical diagnosis of wet or dry AMD or diabetic retinopathy
  • age 50 years and older
  • at least mild depressive symptoms (a score of 5 or more on the PHQ-9)
  • no legal blindness (visual acuity better than 20/200 in better eye).

Exclusion Criteria

  • the current use of cognitive behavioural therapy
  • suicidal intent
  • ocular surgery during the study period (intravitreal anti-VEGF injections will be allowed, e.g. Lucentis)
  • cognitive impairment
  • inability to speak and understand French or English
  • profound hearing impairment.

Outcomes

Primary Outcomes

Change in depressive symptoms

Time Frame: Baseline and 8 weeks

Depressive symptoms will be measured by the PHQ-9, a validated 9 item instrument.

Secondary Outcomes

  • Change in severity of anxiety symptoms(Baseline and 8 weeks)
  • Change in self-efficacy(Baseline and 8 weeks)
  • Change in life space(Baseline and 8 weeks)

Study Sites (1)

Loading locations...

Similar Trials